Daniel R. Tereau - 14 Mar 2022 Form 4 Insider Report for PERKINELMER INC (RVTY)

Signature
/s/ John L. Healy (POA on file) for Daniel R. Tereau
Issuer symbol
RVTY
Transactions as of
14 Mar 2022
Net transactions value
-$830,560
Form type
4
Filing time
15 Mar 2022, 16:05:36 UTC
Previous filing
08 Feb 2022
Next filing
25 Jul 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RVTY Common Stock Options Exercise $279,893 +6,696 +50% $41.80 20,076 14 Mar 2022 Direct F1
transaction RVTY Common Stock Sale $130,692 -805 -4% $162.35 19,271 14 Mar 2022 Direct F2, F3
transaction RVTY Common Stock Sale $179,960 -1,100 -5.7% $163.60 18,171 14 Mar 2022 Direct F2, F4
transaction RVTY Common Stock Sale $279,650 -1,700 -9.4% $164.50 16,471 14 Mar 2022 Direct F2, F5
transaction RVTY Common Stock Sale $133,208 -800 -4.9% $166.51 15,671 14 Mar 2022 Direct F2, F6
transaction RVTY Common Stock Sale $100,716 -600 -3.8% $167.86 15,071 14 Mar 2022 Direct F2, F7
transaction RVTY Common Stock Sale $235,260 -1,391 -9.2% $169.13 13,680 14 Mar 2022 Direct F2, F8
transaction RVTY Common Stock Sale $50,967 -300 -2.2% $169.89 13,380 14 Mar 2022 Direct F2, F9
holding RVTY Common Stock 8 14 Mar 2022 By 401(K)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RVTY NQ Stock Option (right to buy) Options Exercise $0 -6,696 -100% $0.000000* 0 14 Mar 2022 Common Stock 6,696 $41.80 Direct F1, F10
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Exercise Price included on the Form 4 filed on February 10, 2016 for the Reporting Person was incorrectly reported due to administrative error.
F2 The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by Mr. Tereau on February 11, 2022.
F3 The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $161.88 to $162.84. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.
F4 The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $163.00 to $163.94. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.
F5 The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $164.13 to $165.07. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.
F6 The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $165.93 to $166.82. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.
F7 The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $167.36 to $168.14. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.
F8 The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $168.64 to $169.63. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.
F9 The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $169.67 to $170.12. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.
F10 This option became exercisable in three equal annual installments beginning on February 9, 2017, which was the first anniversary of the date on which the option was granted.

Remarks:

Senior Vice President, Strategy and Business Development